Compare PHAR & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHAR | FMNB |
|---|---|---|
| Founded | 1988 | 1887 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 555.3M |
| IPO Year | 2020 | 2010 |
| Metric | PHAR | FMNB |
|---|---|---|
| Price | $12.55 | $14.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $38.33 | $15.00 |
| AVG Volume (30 Days) | 10.2K | ★ 268.1K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 4.89% |
| EPS Growth | N/A | ★ 18.85 |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $279,922,000.00 |
| Revenue This Year | $10.04 | $52.63 |
| Revenue Next Year | $2.51 | $8.28 |
| P/E Ratio | $3,041.22 | ★ $38.62 |
| Revenue Growth | N/A | ★ 3.89 |
| 52 Week Low | $9.54 | $12.23 |
| 52 Week High | $21.34 | $15.50 |
| Indicator | PHAR | FMNB |
|---|---|---|
| Relative Strength Index (RSI) | 32.93 | 55.24 |
| Support Level | $11.43 | $13.73 |
| Resistance Level | $17.41 | $14.37 |
| Average True Range (ATR) | 0.50 | 0.24 |
| MACD | -0.18 | -0.04 |
| Stochastic Oscillator | 20.52 | 61.90 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.